Why would they not?
The one thing the company seems to constantly announce is first patient dosed in trial.
In direct answer to your question regarding expansions.
Did they announced the phase 1B trial expansion for Azercel first patient dosed this year?
Yes they did.
I don't see why MAST bile duct expansion would be treated any different. Those 10 patients will make their own specific data set as will the Azercel expansion.
Why would they not?The one thing the company seems to constantly...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
-0.002(4.35%) |
Mkt cap ! $327.2M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.3¢ | $1.410M | 31.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 4222156 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 2208592 | 2 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |